U.S. markets close in 4 hours 43 minutes
  • S&P 500

    -8.34 (-0.20%)
  • Dow 30

    -194.98 (-0.57%)
  • Nasdaq

    +41.59 (+0.30%)
  • Russell 2000

    -2.02 (-0.09%)
  • Crude Oil

    +0.60 (+0.85%)
  • Gold

    -11.70 (-0.62%)
  • Silver

    -0.05 (-0.18%)

    +0.0022 (+0.18%)
  • 10-Yr Bond

    +0.0200 (+1.37%)

    -0.0000 (-0.00%)

    +0.3600 (+0.33%)

    +4,546.84 (+12.64%)
  • CMC Crypto 200

    +37.90 (+3.91%)
  • FTSE 100

    +35.83 (+0.50%)
  • Nikkei 225

    +213.07 (+0.74%)

Accenture (ACN) to Acquire INSITUM to Boost Interactive Suite

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Accenture ACN recently announced that it has inked a deal to acquire service design and strategic research firm INSITUM.

Founded in 2003, INSITUM is engaged in helping multinational organizations — such as Bancolombia CIB, BBVA, CEMEX, Grupo Bimbo, Roche RHHBY and Uber UBER — manage key innovation challenges by combining design thinking methods with behavioral science, ethnographic research and business strategy. The company has more than 200 designers, researchers and strategists across the United States, Latin America and Europe; additional studios in Barcelona, Bogota, Buenos Aires, Chicago, Lima and Sao Paulo and is also well connected in Africa, Asia-Pacific and the Middle East.

The deal closure is subject to fulfilment of customary closing conditions (which include antitrust clearance). Financial terms have been kept under wraps.

A Strategic Move to Strengthen Latin American Presence

INSITUM will be incorporated under Accenture Interactive in its design and innovation unit, Fjord.

The union of Fjord and INSITUM is expected to generate design and innovation capabilities, which should boost Accenture Interactive’s position as one of the leading experience agencies in the rapidly growing Latin American market (especially in Mexico where INSITUM is headquartered).

Fjord will get a presence in Argentina, Colombia, Mexico and Peru. Its existing operations in Brazil will also be strengthened though the inclusion of talent and forward-thinking capabilities. Notably, with 28 design studios globally, Fjord’s footprint has quadrupled under Accenture Interactive, thereby strengthening its position as one of the renowned design firms in the world.

“With INSITUM, we will boost Accenture Interactive’s reach in the region and improve our Fjord design capability, which is a crucial component of our mission to deliver the best, most meaningful experiences to people. We’re thrilled about the possibilities of what we can achieve together,” stated Eduardo Bicudo, LatAm lead of Accenture Interactive.

Accenture’s prior initiatives in strengthening its Latin American presence included the acquisition of Spanish advertising agency, Shackleton in April 2019; Brazilian content marketing agency, New Content in December 2018 and Brazilian digital agency, AD.Dialeto in August 2015. The company has been witnessing organic growth in the region on the back of robust demand from pan-regional clients.

We believe Accenture’s acquisition strategy helps it broaden its product portfolio and market share and boosts revenues, apart from strengthening its competitive market position.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Roche Holding AG (RHHBY) : Free Stock Analysis Report
BanColombia S.A. (CIB) : Free Stock Analysis Report
Accenture PLC (ACN) : Free Stock Analysis Report
Uber Technologies, Inc. (UBER) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research